Tagged glaucoma
Press Release
Investigational Optejet® Microdose Dispenser from Eyenovia Shows Promise in Improving Treatment for Myopia, Presbyopia and Patients Getting Eye Exams
The Optejet® ophthalmic drug device is designed to precisely administer medication to the eye, potentially treating patients' conditions through gentler, more efficient dosing. Read More
Press Release
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye. Read More
Press Release
Glauconix Biosciences Awarded National Science Foundation Phase IIB Small Business Innovation Research Grant
3D Human Tissue Retina Vasculature model provides a new and novel approach to rapidly and efficiently screening numerous therapies for diabetic retinopathy and diabetic macular edema. Read More
Press Release
Glauconix Biosciences Expands Scientific Advisory Board for 3D Human Tissue Retina Vasculature Model With the Addition of Leading Expert Dr. Patricia D'Amore
Appointment reflects Glauconix Biosciences' expansion of their 3D Human Tissue model platform within the Ophthalmology space and brings their second commercial model closer to market Read More
Press Release
Unique Tonometer, Diaton, Helps to Meet and Exceed Joint Commission Guideline for Disinfection and Sterilization
Diaton Tonometer is a unique and innovative tonometry instrument, unlike all others; allows to accurately measure Intraocular Pressure (IOP) through the eyelid and sclera without touching the eyeball. With Diaton use, there is no risk of infection or need for sterilization, as there is no contact with the mucous membrane. Zero-contact with the cornea or influence of corneal biomechanics on Diaton IOP results provides more accurate glaucoma diagnosis. Read More
Press Release
IQ4I Publishes a Report on "Ophthalmology Devices Global Market - Forecast to 2021"
The global Ophthalmology devices market is expected to reach $42.0 billion by 2021. This report analyzes the ophthalmology devices market in terms of market revenue ($ million) for all segments. Read More
Press Release